PAVmed (PAVM) Year-over-year earnings per share growth for the last twelve months

Graphic logo of pavmed.com (PAVM)

PAVmed Inc. possesses pricing power due to its unique early screening diagnostics. The volatility of the quarterly EPS reflects profit dynamics, where the value of 95.50 represents the most recent figure. The company acts as a medical incubator with a diversified portfolio of subsidiary entities. Currently, the business is focused on the commercialization of the EsoGuard test and the integration of its innovations into US medical standards.

PAVM: PAVmed Quarterly EPS earnings growth 07/04/2022 - 11/14/2026

PAVmed Inc. (PAVM) - metric breakdowns and financial figures

- share price and expert price forecast:
Stock Price pavmed.com|PAVM - Average Forecast Price
- market capitalization details:
Market Value PAVmed Inc|PAVM - Total Enterprise Value
- book capitalization data:
Accounting Value per Share PAVmed|PAVM - Book Capitalization|Market Value to Book Value Ratio pavmed.com|PAVM - Company Total Asset Base
- company liabilities and liquidity data:
Total Debt to Equity Ratio PAVmed Inc.|PAVM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity pavmed.com|PAVM - Company Total Debt|Debts to Book Capitalization PAVmed Inc|PAVM - Long-Term Debt|Company Short-Term Debts PAVmed|Quick Ratio pavmed.com
- earnings and valuation multiples information:
PAVM - Net Financial Result|Projected Future Earnings PAVmed Inc.|PAVM - Price to Earnings Ratio|Forward P/E Multiple pavmed.com|PAVM - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PAVmed Inc|PAVM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months PAVmed|PAVM - Earnings per share for the trailing year|Quarterly EPS earnings growth pavmed.com|PAVM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year PAVmed Inc.
- revenue and sales details:
PAVM - Company Total Sales Volume|Company Future Sales Volume pavmed.com|PAVM - P/S Multiple|Forward P/S Multiple PAVmed Inc
Basic company analysis:PAVmed, Inc. - PAVM
Finished products of pavmed.com

This indicator serves as a stress-testing tool for positions, allowing speculative noise to be filtered out from real capitalization growth. The quarterly EPS dynamics metric measures the rate of change in net income per share, reflecting the efficiency of PAVmed Inc. in managing expenses for costly secured medical equipment logistics and its impact on the business's bottom-line profitability.

Analysis of competing companies

SYK: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Medtronic Inc. (MDT)|Year-over-year earnings per share growth for the last twelve months Koninklijke Philips NV|Earnings per share growth in annualized terms for the last twelve months Smith+Nephew SNN|Year-over-year net earnings per share growth for the last 12 months HOLX (Hologic, Inc.)|Quarterly EPS earnings growth carlisle.com (CSL)|Year-over-year earnings per share growth for the last twelve months Integer ITGR|Year-over-year net earnings per share change for the last twelve months LivaNova plc (LIVN)|AHCO: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SSII (SS Innovations International)|Avanos Medical, Inc. (AVNS) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Shoulder Innovations|VMD (Viemed) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Inogen Medical INGN|Quarterly EPS earnings growth OWLT|Quipt - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth POCI (Precision Optics Corporation)|Year-over-year net earnings per share change for the last twelve months tivichealth.com (TIVC)|Movano - Quarterly EPS earnings growth|Holdco Nuvo Group (NUVO) - Year-over-year net earnings per share growth for the last 12 months